Tag: opioid addiction

  • Judge Rules Firing Of Nurse Caught Stealing Opioids "Unfair" Because Of Addiction

    Judge Rules Firing Of Nurse Caught Stealing Opioids "Unfair" Because Of Addiction

    The nurse had falsified patient requests for drugs, used them, and then further falsified records that the medications were delivered to the patient.

    A nurse who was caught injecting herself with opioids she had reported as being delivered to patients has had her name cleared of wrongdoing because a judge has ruled her addiction a disease.

    Not only has the long-term care facility where she works been forced to take her back on the job, but the Regional Municipality of Waterloo has also been ordered to financially compensate the nurse for “injury to dignity, feelings and self-respect.”

    The presiding judge, arbitrator Larry Steinberg, argued that the nurse suffered from the disease of severe opioid use disorder, leaving her with “a complete inability or a diminished capacity” to resist stealing and using opioid medications meant for patients at her place of work.

    The nurse in question, named in records only as DS, was found to have falsified patient requests for drugs, used them, and then further falsified records that the medications were delivered to the patient. A fellow nurse also caught DS using patients’ drugs in the restroom.

    Faced with accusations from management, DS at first denied using the drugs but later admitted to becoming addicted after using drugs as part of her treatment for a kidney condition.

    The incidents that DS stands accused of happened in 2016, and DS said she has not used any such drugs since going to rehab later that year.

    Legal representatives for the long-term care facility argued that reinstating DS’ employee status would burden the facility with “undue hardship.” They claimed that if DS were to steal a fentanyl patch from one of the many patients there who suffer from dementia, the patients would not be aware enough to realize it and report her.

    Additionally, other nurses cannot be depended on to go above and beyond their duties to monitor DS to ensure she does not commit further thefts. Furthermore, they argued, DS was not fired for being addicted but for falsifying records and stealing.

    However, Steinberg ruled that the theft and falsification of records were symptoms of a disease DS suffered from.

    The nature of addiction became central to the case. An addiction expert who was brought in to weigh in on the case, a professor of psychiatry named Lawrie Reznek, testified that addiction is more like a “bad habit” than a disease. He did admit that his opinion “was a minority view in the psychiatric profession and that it was contrary, for example, to the DSM-5.”

    Steinberg argued that calling addiction a “bad habit” actually “stigmatizes these conditions and makes it harder for people to get help.” Science backs the judge’s opinion, as studies have found addiction to affect those with genetic predispositions to it and actually change the brain and body in measurable ways. 

    However, the Canadian justice system has not historically treated addiction as such, convicting several nurses accused of similar crimes.

    View the original article at thefix.com

  • Maine's First Female Governor Targets Opioids

    Maine's First Female Governor Targets Opioids

    Governor Janet Mills is making the opioid epidemic in her state her top priority.

    Democratic Governor Janet Mills is making the opioid crisis in her state her top priority. Going the complete opposite direction of her predecessor, she has expanded Medicaid and made plans to appoint an opioid czar in her first days in office.

    Her Medicaid expansion would allow thousands of additional Maine citizens into the program, including those who need assistance in fighting opioid addictions.

    “A major part of the health care crisis is the opioid epidemic,” Governor Mills said in her inaugural address. To combat the epidemic in Maine, Mills said on Twitter she wants to appoint a czar to “marshal the collective power and resources of state government,” hoping to prevent deaths such as the 418 overdose deaths in Maine last year.

    Mills’ predecessor, former Republican Governor Paul LePage, was not constructive in approaching the drug crisis, suggesting the problem had something to do with race. In August 2016, LePage claimed he had a binder that showed a massive majority of busted drug dealers were black or Hispanic

    “I don’t ask them to come to Maine and sell their poison, but they come,” LePage said. “And I will tell you that 90-plus percent of those pictures in my book, and it’s a three-ringed binder, are black and Hispanic people from Waterbury, Connecticut, the Bronx and Brooklyn.”

    An audit of the binder revealed roughly half of the offenders in the binder appeared to be white. After being accused of being a racist, LePage denied the charges and claimed he was just stating facts.

    “You’ve been in uniform? You shoot at the enemy,” he once said at a statehouse press conference. “You try to identify the enemy and the enemy right now, the overwhelming majority of people coming in, are people of color or people of Hispanic origin.”

    Treatment advocates have high hopes for Mills’ plan.

    Gust Stringos is the medical director of a family practice in Skowhegan, a small town in Maine with a population of 8,000. He said half of his patients are battling opioid addiction.

    “Many of them were on Medicaid and then lost it in the era of LePage,” he said.

    He recalls one 21-year-old female who relapsed after losing coverage and dropping out of the treatment program. When she got pregnant, she requalified and was readmitted.

    “If she had been able to stay on Medicaid in the first place, she wouldn’t have gotten pregnant and wouldn’t have relapsed,” said Stringos. “That’s a typical story of people losing insurance and what happens.”

    View the original article at thefix.com

  • "Times" Readers Share Stories Of Addiction & Recovery

    "Times" Readers Share Stories Of Addiction & Recovery

    New York Times readers shared their personal experiences with opioid addiction and recovery.

    The opioid epidemic can be covered with statistics and numbers: the 72,000 Americans who died of drug overdoses in 2017 or the five-fold increase in babies born dependent on drugs.

    However, that only captures some of the picture. To really grasp the effects of the opioid epidemic, The New York Times asked readers at the end of last year to share their experiences with addiction and recovery

    Charlotte, North Carolina resident Cindy Chandler, 64, reminded readers that the issue of drug addiction has been affecting families since long before it started getting press coverage. Her brother overdosed on heroin in 1997 at age 40. 

    “He took the entire family on psychological roller coaster rides throughout his life. We never knew when the phone rang from then on if it was the end for him,” Chandler wrote. “Turns out it took 28 more years of family torture.”

    Some readers, including Michele Sevik, a 58-year-old from Vermont, described the initial euphoria that kept them coming back to opioids.

    “It was like offering an emotional and social paraplegic a drug that would suddenly allow them to hop out of their wheelchairs and walk and run,” Sevik wrote. “Even knowing about addiction, even knowing about HIV, it was irresistible.”

    Stephen DePasque, a 35-year-old from Pennsylvania, was more productive than he had ever been when he started using opioids, but the new energy was short lived. 

    “Before long, the upkeep of my back-pocket superpower took the top spot on my priority list,” he wrote. 

    St. Louis resident Heather Hudson, 27, found that even facing the heartbreak of addiction head on wasn’t enough to make her stop using. 

    “At age 26, my little brother and I found our big brother dead on the floor from an accidental fentanyl overdose. I actually took the rest of his dope and did it in a McDonald’s bathroom while the coroner was loading him into a van,” she wrote. “As sick and twisted as that is. But that’s addiction. Sick and twisted. It’s like being in an endless tunnel. You can see the light at the end, but you never feel like you’ll reach it.”

    Despite the heavy answers, some readers wrote in to share hope for recovery. 

    “Recovery is not an exact science, or a recipe that can be applied to different people in different ways. But many of us do recover,” wrote Katharine, a 29-year-old from Philadelphia. “I wish I knew the answer to this current crisis. All I can do is keep my hand open and available to the next person who may need help.”

    View the original article at thefix.com

  • Will A Border Wall Help Curb The Opioid Epidemic?

    Will A Border Wall Help Curb The Opioid Epidemic?

    Experts discuss the impact, if any, a new border wall would have on stemming the flow of drugs entering the US through Mexico.

    As the government shutdown continues, President Trump is digging in his heels, insisting that an expensive border wall is essential to national security, in part because it would hamper the flow of opioids into the country. 

    “Our southern border is a pipeline for vast quantities of illegal drugs, including meth, heroin, cocaine, and fentanyl,” Trump said during a prime time speech from the Oval Office on Tuesday, according to Vox. “Every week, 300 of our citizens are killed by heroin alone, 90 percent of which floods across from our southern border. More Americans will die from drugs this year than were killed in the entire Vietnam War.”

    While it’s true that the number of Americans dying from drug overdoses is shocking, and that most of the drugs consumed in the US come over the Mexican border, it’s silly to think that a wall will stop that flow. That’s because most drugs come into the country via legal posts of entry, usually smuggled in vehicles.

    In fact, the Drug Enforcement Administration has said that only a “small percentage” of drugs are carried over the boarder at illegal entry points, according to The Atlantic

    In addition, if a wall was erected, cartels would simply adjust the ways they reach the lucrative US market, according to Elaine Carey, dean of the College of Humanities, Education and Social Sciences at Purdue University.

    Cary told The Washington Post, “Drug trafficking businesses are very nimble organizations. The way opioids flow or any drug or narcotic, it’s from all different ways. Yes, it comes across the border, but it comes through airports, ships, on trucks, too. A wall’s not going to do anything unless you deal with the demand.”

    Without addressing the causes of addiction on American soil, building a wall would do little to diminish availability of drugs, she said. 

    “If we build the wall, demand is still going to be there.”

    If Trump really wanted to reduce the amount of drugs coming into the country, he would be better off investing in additional border security staff than spending billions on a wall, according to Christopher Wilson, deputy director of the Mexico Institute at the Woodrow Wilson International Center for Scholars.

    “A wall alone cannot stop the flow of drugs into the United States,” Wilson told Vox in 2017. “If we’re talking about a broader increase in border security, there could be some — probably minor — implications for the overall numbers of drugs being trafficked. But history shows us that border enforcement has been much more effective at changing the when and where of drugs being brought into the United States rather than the overall amount of drugs being brought into the United States.”

    View the original article at thefix.com

  • Firefighters Open Treatment Center For Their Own

    Firefighters Open Treatment Center For Their Own

    The center provides beds for 60 firefighters to get treatment for substance use disorder, mental illness or other behavioral health conditions.

    The opioid epidemic has touched people from all walks of life, including first responders, who often find it hard to reach out for help in a work culture that involves putting others first and brushing vulnerabilities aside. That’s why a new treatment center has opened, aimed specifically at helping firefighters who need support with addiction and mental health issues. 

    The International Association of Fire Fighters (IAFF) opened the Center of Excellence for Behavioral Health Treatment and Recovery last year just outside Washington, DC. It is set up similarly to a firehouse and provides beds for 60 firefighters to get treatment for substance use disorder, mental illness or other behavioral health conditions, whether they are associated with work or not. 

    “It’s really a state-of-the-art facility for our membership,” Ray Maione, a captain in the Phoenix Fire Department and vice president of member services for the United Phoenix Firefighters, Local 493, told Arizona Family. “To see it come to fruition is really pretty impressive; a lot of work went into this.”

    Maione said that the services are much needed for firefighters who are hesitant to seek help. 

    “We’re problem solvers, I mean we run into burning buildings when they’re on fire, so people think, and we think, we’re invincible,” he said. “And sometimes it just builds up. . . . When a firefighter reaches out I know they’ve already exhausted every option they have and they’re in crisis.”

    On-the-job injuries can expose firefighters to potent painkillers, and traumatic events can erode firefighters’ mental health, he said. 

    “We started to notice a big increase in suicides, a big increase in opioid addiction,” Maione said.

    Tyler Ramsey, a firefighter, first started using opioids for a back injury but noticed with time that he was becoming dependent on the pills. 

    “You get a prescription for an opiate or a pain medication, and at the start it’s need-based,” said Ramsey. “. . . Once it gets a hold of you, you use that as a crutch.”

    He told himself that because a doctor prescribed the pills they weren’t dangerous. 

    “I guess it gives you a false sense of security, almost, that it’s prescribed by a medical professional,” Ramsey said. “But being a fireman, I thought, ‘Oh I can control this. I don’t need to ask for help. I can manage this.’”

    However, when thoughts of opioids began taking over his day-to-day life, he realized he had a substance use problem. 

    “It’s the last thing you think about before you close your eyes at night and the first thing when you open your eyes in the morning, which is a pretty terrible place to be,” he said. When Ramsey reached out to colleagues, they got him into rehab that day, and they help him stay sober. 

    “I’m happy, upright, breathing and living a normal life again,” he said. “I feel like I’ve been afforded a second chance.”

    View the original article at thefix.com

  • The State Of Harm Reduction Around The Globe

    The State Of Harm Reduction Around The Globe

    A new report breaks down the status of harm reduction programs around the world. 

    Even as opioid use continues wreaking havoc on some parts of the globe, the availability of harm reduction measures worldwide are relatively stagnant, as documented in a massive new report released this month.

    The number of countries with needle exchange or opioid substitution treatment has stayed relatively stable over the past four years, and a lack of funding in middle- and low-income countries has stunted the growth of service options available in some of the places most severely impacted, according to the “Global State of Harm Reduction” 2018 report issued this month by Harm Reduction International

    But there’s a significant exception to that trend: North America. Here, as opioid overdose figures rise, the harm reduction response is blossoming. Naloxone access, fentanyl testing strips, and needle exchange programs have become more common in the US and Canada – all possible signs of forward-thinking responses to a well-documented crisis. 

    “The US now has the fastest annual percentage rise of drug-related fatal overdose ever recorded,” the report notes, “with an increase of 21.4% between 2015- 2016 alone.” 

    Currently, the United States has 335 needle exchanges – a 37% increase since the last harm reduction report. Meanwhile, Canada has taken harm reduction efforts a step further, opening a total of 26 supervised injection sites. That sort of progressive action is still barred by federal law in the US, though some communities have considered addressing it both legislatively and in local action plans.

    There are, of course, still significant gaps. The availability of harm reduction in prisons is “woefully inadequate, falling far short of meeting both international human rights and public health standards,” according to the report. 

    And, despite the response in North America, service offerings worldwide have stayed more stagnant.

    “While our coverage of harm reduction policies and services has evolved and broadened in scope, the same cannot always be said for harm reduction in practice around the world,” the report notes. “Despite [the] heavy burden of diseases, effective harm reduction interventions that can help prevent their spread are severely lacking in many countries.”

    Currently, 86 countries offer some sort of needle exchange program – down from 90 in 2016. Bulgaria, Laos and the Philippines have shuttered their exchange programs in the face of punitive drug policies, while Argentina and Brazil have stopped offering such services as the number of injection drug users falls in those nations. 

    While the number of countries that offer exchanges has fallen slightly, the number with opioid substitution drugs available has gone up a bit. Since 2016, Cote d’Ivoire, Zanzibar, Bahrain, Kuwait, Palestine, Argentina and Costa Rica have all introduced or re-introduced medication-assisted treatments. 

    Overall, methadone is still the most commonly prescribed of those treatments, with buprenorphine falling into second place. Despite research espousing the use of heroin-assisted treatment as a harm reduction option, it’s only available in seven countries: Belgium, Canada, Denmark, Germany, the Netherlands, Switzerland and the UK. Though that’s still considered a radical option in many countries, it’s just one of the solutions experts have increasingly examined as more potent drugs continue appearing in underground supply chains.

    “The rise of illicit fentanyls themselves is just about the clearest case one can make for harm reduction: despite a literally poisonous supply, millions of people are still taking street opioids in an underground market that lacks quality control,” journalist Maia Szalavitz wrote in an introduction to the report. “It’s hard to argue that anything short of providing a safer supply – both through traditional medications like methadone and buprenorphine and via prescription heroin, hydromorphone (Dilaudid) and perhaps others – will be able to end the crisis, if done to scale.”

    And, aside from the continued toll of opioid use, amphetamine use is on the rise as well – but harm reduction options for speed users “remain underdeveloped,” according to the report. Safe consumption sites – in the regions where they’re available – continue to focus largely on injection use, leaving out those who smoke or snort their drugs. And, free drug testing services are limited mostly to festivals and clubs. 

    “While this all paints a bleak picture of harm reduction worldwide, there are examples of innovation and perseverance in this report that give hope and demonstrate that progress is possible,” the report’s authors wrote. “It is important, too, to not overlook the fact that harm reduction has come a long way over the past two decades. The evidence is clearly in favour of harm reduction. It is time that more countries acknowledge this and implement the services that are proven to advance public health and uphold human rights.”

    View the original article at thefix.com

  • Opioid Vaccine Shows Promise in Early Testing

    Opioid Vaccine Shows Promise in Early Testing

    Alongside its potential use as an opioid vaccine, the experimental medicine may also help first responders who accidentally come in contact with synthetic opioids. 

    Researchers have reported that a newly developed vaccine that could combat both opioid dependency and overdose has yielded what appear to be positive results in animal testing. The vaccine, which uses monoclonal antibodies – antibodies made by identical copies of immune cells – appeared to block both the analgesic properties of synthetic opioids like fentanyl, as well as their high propensity of producing a fatal overdose, when administered in preliminary tests.

    The researchers have begun developing antibodies in the hope of testing their vaccine on humans.

    Researchers from The Scripps Research Institute, which conducted the tests, presented their findings on December 13 at the annual meeting of the American College of Neuropsychopharmacology. The study detailed the creation of the monoclonal antibodies as well as two tests of their efficacy involving mice.

    In the first test, the research team measured pain response using a heated beam of light that was applied to a mouse’s tail. An immediate response – specifically, the mice removed their tail from the light – suggested that the animal experienced a degree of pain, while a delayed response suggested that the pain had been dulled.

    Mice were then given a synthetic opioid such as fentanyl and exposed to the light beam, which produced a longer response time due to the pain-dulling properties of the drug. However, when given the antibodies, the researchers found that the mice withdrew their tails at a faster rate, which suggested that the vaccine had blocked the drug’s analgesic effect.

    In the second test, mice were given the vaccine, followed by a dose of fentanyl that had proven fatal in other test animals. According to the study, the mice did not experience overdose. In both tests, the antibodies proved effective against seven other synthetic opioids, including carfentanil, which the Centers for Disease Control (CDC) described as the “most potent fentanyl analog detected in the United States” and which has been linked to a number of overdose deaths.

    As US News and World Report noted, research of this nature involving animals does not always produce the same results in human test subjects, so the study authors are in the process of developing human antibodies and hope to test them in the future.

    “Antibodies persist longer, and thus have enormous promise for addressing both opioid addiction as well as overdose,” said study leader Kim Janda in a press release.

    In addition to the vaccine’s possible use with drug users, Janda and his fellow authors believe that it may have a practical application as a safeguard for individuals who may come in contact with synthetic opioids. “These antibodies could be used to protect police, EMTs and other first responders from inadvertent acute fentanyl exposure,” he said, adding that a canine version could also be applicable for drug-sniffing dogs.

    View the original article at thefix.com

  • DEA, Drug Distributors Failed To Protect West Virginia, Report Says

    DEA, Drug Distributors Failed To Protect West Virginia, Report Says

    A new report highlighted the way millions of opioids flooded small towns in West Virginia over a 10-year-period with ineffective government oversight.

    Despite the fact that “inordinate volumes of opioids” were flowing into West Virginia between 2006 and 2015, drug distributors continued to fill outrageous orders, and the Drug Enforcement Administration took ineffective measures to enforce regulations that could have slowed the flow of opioids, according to a federal report released last week. 

    The report, “Red Flags and Warning Signs Ignored: Opioid Distribution and Enforcement Concerns in West Virginia,” was prepared by House Energy and Commerce Committee.

    It found that in 10 years, 20.8 million opioids were sent to pharmacies in the town of Williamson, which has a population of just 3,000. Another town, Kermit, which has a population of just 364 people, received 9 million. Overall, between 2007 and 2012, West Virginia pharmacies received more than 780 million hydrocodone and oxycodone pills.

    “These troubling examples raised serious questions about compliance with the Controlled Substances Act (CSA), administered by the Drug Enforcement Administration (DEA),” report authors wrote. 

    The report reviewed the practices of drug distributors, who are responsible for filling orders by pharmacies. Five companies, including the three largest in the country and two regional distributors, were reviewed. These were AmerisourceBergen Drug Corporation, Cardinal Health, Inc., H.D. Smith Wholesale Drug Co., McKesson Corporation, and Miami-Luken, Inc. 

    The companies have a legal obligation to alert the DEA when they suspected that drugs were being diverted into illegal use. However, case studies reviewed in the report “raise sufficient concerns as to whether these companies fulfilled their legal obligations to prevent drug diversion.”

    In fact, “the extraordinary volume of shipments in West Virginia was a signal of possible breakdowns in distributors’ oversight of their customers, including their suspicious order monitoring systems. Yet the actions taken by both distributors and the DEA contributed to — and failed to stop — this problem,” report authors wrote. 

    The report also found that the DEA’s Automation of Reports and Consolidated Orders System, which is meant to help detect abnormal drug distribution patterns in real time, was not used to monitor distribution, but only to reinforce cases after they’d been flagged through other means. Additionally, the agency revoked the registration of fewer doctors and pharmacies thought to be contributing to drug diversion during the height of the pill crisis. 

    Authors of the report said that the findings could help explain how the opioid epidemic unfolded across the nation. 

    “Taken altogether, the Committee’s report outlines a series of missteps and missed opportunities that contributed to the worsening of the opioid epidemic in West Virginia,” they wrote. “This investigation identified flaws limiting the effectiveness of the distributors’ compliance programs and DEA’s enforcement. While focused on a narrow part of West Virginia, the report raises grave concerns about practices by the distributors and the DEA nationwide.”

    View the original article at thefix.com

  • Heartbreaking Billboard Aims To Raise Awareness About Addiction

    Heartbreaking Billboard Aims To Raise Awareness About Addiction

    The billboard spotlights a brief, powerful message: “Tim Hatley: Addiction Can Lead to Death.”

    Amidst the pre-fab buildings and snow of northern Michigan sits a stark reminder for the Hatley family.

    It’s a roadside billboard with a simple message: “Tim Hatley: Addiction Can Lead to Death.” 

    On a rural road outside the town of Grayling – population 1,800 – the signage is aimed at raising awareness about addiction, using the story of a former high school football player who died by suicide last year after struggling with addiction. 

    “When he turned 19 he moved out of my house and moved down the street with a friend and that’s kind of when it all started that he started snorting Norcos,” his mother Karen told CBS affiliate WWTV. “He had a huge addiction with the Norcos, went through three withdrawals with him.”

    It started after he was prescribed painkillers for a sports injury. Afterward, he kept using the pills and pain management gave way to a larger problem. After more than a decade of drug misuse, he turned from opioids to meth, his mother said. 

    A month before his death, he had a psychotic episode. On Dec. 30 of last year he killed himself.

    “His fiancé had called me and said ‘he’s gone’ and hung up on me. And I was like ‘what is she’s talking about?’” Hatley told the TV station. “I called my husband and said ‘you need to come home now.’ So, he came home, and when he walked in he was crying, and just shook his head and I fell to the ground.”

    So this year, she paired up with the Crawford County Partnership for Substance Abuse Prevention to put up a billboard reminding passersby of her son’s story and offering a solution. “If you need help, recovery starts here. Call 1-800-834-3393,” the sign says.

    “I chose the billboard going towards the high school because I want kids on a bus to see that every single day, and I want parents to get the message that you know, you’re [sic] kid doesn’t have to be a troubled kid to end up this way,” Hatley said. “This loss is the worst thing I’ve ever had to go through, and I don’t want anyone else to go through this.”

    View the original article at thefix.com

  • New Website Helps People Find Addiction Treatment Services

    New Website Helps People Find Addiction Treatment Services

    The live, online resource helps connect individuals and family members seeking addiction treatment options and related services throughout Pennsylvania.

    A series of simple questions may be a crucial link for Pennsylvania residents struggling with drug dependency.

    The Drug and Alcohol Referral Tool (DART) is a live, online resource that can connect individuals and family members seeking addiction treatment options and related services in their area. Visitors answer 9 yes-or-no questions on age, county, history of dependency on drugs or alcohol, military service and other criteria. Their answers then generate contacts for county-specific treatment or support, which has been an ongoing goal of Governor Tom Wolf’s administration.

    As The Daily Item noted, DART is an extension of Pennsylvania’s Get Help Now Hotline (800-662-HELP), which connects individuals in need with trained professionals. Though the hotline received 35,000 calls over the last two years, Department of Drug and Alcohol Programs Secretary Jen Smith said, “What we’ve heard was the hotline wasn’t really enough.”

    To accommodate the need for resources, the department, working in conjunction with the Pennsylvania Department of Human Services, launched DART on December 6, 2018. The online questionnaire, which is anonymous and can be translated into more than 100 languages, asks visitors if they are inquiring for themselves or a loved one.

    From there, they are asked to click yes or no to answer nine questions, two of which – age and county – are mandatory. The rest, which cover the individual’s military service, history of drug, alcohol or gambling abuse, and need for legal and/or transportation services, are optional.

    Upon completing the questions, respondents are then provided with a list of resources in their area, based on their answers. These include substance dependency and mental health office phone numbers, links to health and human services programs through the state’s COMPASS network based on income and a map of Drug Take Back boxes, among other options. Eligibility for programs is not assessed by DART, but users can be directed to additional information on qualifications.

    Income, transportation and living situation are included on the questionnaire because the problems are often hand-in-hand. “Substance use disorders often occur when a person experiences other medical and behavioral health concerns, and they may need additional resources to live stable, healthy life in recovery,” said Human Services Secretary Teresa Miller. “Connecting people seeking treatment to comprehensive services that can help meet all of their needs from the start is critical as they work towards recovery.”

    Inclusive tools like DART are a crucial part of Wolf’s plan to aid his state, which as of 2017 had the highest rate of drug overdose mortalities in the United States. DART is just one of several initiatives being rolled out to promote Stop Overdoses in PA: Get Help Now Week, which takes place December 10 through 14, 2018.

    “A common concern that we have heard throughout the commonwealth is that individuals aren’t aware of the services and supports available to them,” said Smith. “[DART] will allow individuals to have critical information on where to go and how to access the services they need.”

    View the original article at thefix.com